Abstract
Binding of [3-H]-dihydroalprenolol ([3-H]-DHA) to rat cardiac membranes was rapid and reversible (k1 = 0.633-0.701 x 10(6) M(-1) S(-1) And k(-1) = 0.0017-0.0043 s(-1). 2 [3-H]-DHA bound to a single class of binding sites with an equilibrium dissociation constant (Kd25degreesc) of 5.7+/-1.1 x 10(-9) M. 3 This binding was specific and the order of potency of adrenoceptor agonists in competing for the binding sites was (-)-isoproterenol greater than (+/-)-isoproternol greater than (+)-isoproterenol greater than (-)-adrenaline greater than (-)-noradrenaline. This was in agreement with the beta1 nature of the cardiac beta-receptors. 4 Cardioselective beta-blockers (i.e. metoprolol, acebutolol and practolol) were shown to have lower binding site affinities, when compared to other blockers. This may be related to steric hindrance by the side-chain at the aromatic end of these molecules.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown E. M., Gardner J. D., Aurbach G. D. Direct determination of ligand interactions with beta-adrenergic receptors on intact turkey erythrocytes: correlation of binding with biological activity. Endocrinology. 1976 Nov;99(5):1370–1376. doi: 10.1210/endo-99-5-1370. [DOI] [PubMed] [Google Scholar]
- Harden T. K., Wolfe B. B., Molinoff P. B. Binding of iodinated beta adrenergic antagonists to proteins derived from rat heart. Mol Pharmacol. 1976 Jan;12(1):1–15. [PubMed] [Google Scholar]
- Harms H. H. Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors. J Pharmacol Exp Ther. 1976 Nov;199(2):329–335. [PubMed] [Google Scholar]
- Kaumann A. J., Birnbaumer L. Studies on receptor-mediated activation of adenylyl cyclases. IV. Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase: stereospecificity for ligands and determination of apparent affinity constants for beta-blockers. J Biol Chem. 1974 Dec 25;249(24):7874–7885. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lefkowitz R. J., Williams L. T. Catecholamine binding to the beta-adrenergic receptor. Proc Natl Acad Sci U S A. 1977 Feb;74(2):515–519. doi: 10.1073/pnas.74.2.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosei E. A., Brown J. J., Fraser R., Lever A. F., Morton J. J., Robertson J. I., Trust P. M. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension. Aust N Z J Med. 1976 Aug;6(3 Suppl):83–88. doi: 10.1111/j.1445-5994.1976.tb03341.x. [DOI] [PubMed] [Google Scholar]